GlassScriptPhysician profile
Benjamin J Leak
NPI 1043248867
$6,645.01
in general payments reported to CMS, 2019-2025
46 companies · $1,222 in 2025
The $1,222 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $480 · 2021: $899 · 2022: $958 · 2023: $1,184 · 2024: $1,225 · 2025: $1,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,413 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,413.18 |
| Education | $218.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $818.98 | 2019-2025 | |
| Astellas Pharma US INC | $656.71 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $623.29 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $598.00 | 2019-2025 | Erleada |
| Convatec INC. | $485.02 | 2019-2024 | |
| Endo USA, INC. | $317.34 | 2024-2025 | Xiaflex, Aveed, Edex |
| Endo Pharmaceuticals INC. | $293.16 | 2019-2024 | Edex, Aveed, Xiaflex |
| Pfizer INC. | $246.82 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $246.06 | 2020-2024 | Prolaris, Myrisk |
| Ferring Pharmaceuticals INC. | $209.56 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $185.53 | 2020-2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $154.87 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Olympus America INC. | $143.58 | 2021-2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $141.47 | 2020-2023 | Lynparza |
| Myovant Sciences INC. | $126.93 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Leak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.